MDM2-MOF-H4K16ac axis contributes to tumorigenesis induced by Notch

Yan Liu1, Zhao-Bin Xing, Shu-Qing Wang

  • 1College of Life Sciences, Hebei United University, Tangshan, China; Central Laboratory, Cancer Institute, Tangshan People's Hospital, China.

The FEBS Journal
|June 6, 2014
PubMed

Insights

Aberrantly high Notch signaling downregulates H4K16ac in cancers. Increased MDM2 upregulates MALT1 degradation, attenuating Notch-induced heterogeneity in hepatocellular carcinoma and breast cancer.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Notch signaling plays a critical role in cell development and is often dysregulated in various cancers.
  • Epigenetic modifications, such as histone acetylation, are crucial regulators of gene expression and can be altered in cancer.
  • Understanding the interplay between Notch signaling and epigenetic mechanisms is vital for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the epigenetic mechanisms underlying Notch signaling in hepatocellular carcinoma (HCC) and breast cancer.
  • To identify specific histone modifications associated with aberrant Notch activity.
  • To explore the potential of targeting these mechanisms for therapeutic intervention.

Main Methods:

  • Analysis of H4K16ac levels in HCC and breast cancer cell lines and tissues with varying Notch activity.
  • Investigation of the role of murine double minute 2 (MDM2) in regulating the degradation of the first (MALT1).
  • Assessment of the impact of MALT1 degradation on Notch signaling-induced cellular heterogeneity.

Main Results:

  • Aberrantly high Notch activity correlated with decreased H4K16ac levels in HCC and breast cancer.
  • Increased MDM2 expression led to enhanced MALT1 degradation, contributing to H4K16ac downregulation.
  • Elevated MALT1 degradation effectively attenuated cellular heterogeneity driven by excessive Notch signaling.

Conclusions:

  • The study identifies a novel epigenetic regulatory pathway involving MDM2-MALT1-H4K16ac in Notch-driven cancers.
  • This pathway offers new insights into the molecular basis of hepatocellular carcinoma and breast cancer.
  • Targeting the MDM2-MALT1 axis may represent a promising therapeutic strategy for Notch-induced cancers.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K